Pfizer Inc
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday hiked its full-year adjusted profit guidance on its cost cuts and strong business performance this year. The company also reported second-quarter results that topped Wall Street’s estimates for the […]
Read More
S&P 500 futures inch higher after benchmark snaps losing streak, Palantir pops on earnings: Live updates
Traders work at the New York Stock Exchange on July 30, 2025. NYSE Stock futures were slightly higher on Monday night, following Wall Street’s rebound, as investors followed the latest batch of corporate earnings. Dow Jones Industrial Average futures added 54 points, or 0.1%. S&P 500 futures and Nasdaq 100 futures each also added 0.1%. […]
Read More
Trump’s drug price ultimatum sets pharma firms scrambling
Key Points A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday. President Trump sent letters to 17 major firms outlining the steps they must take to cut costs. Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs. Pharmaceutical firms are scrambling to respond […]
Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]
Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]
Read More
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients at a more than 40% discount. The move comes as the Trump administration ramps up pressure on the pharmaceutical industry to cut drug prices, and threatens to impose sweeping tariffs on pharmaceuticals imported into the […]
Read More
Inside the trade war’s tariff hideouts, ‘foreign’ zones and bonded warehouses
To offset the rising costs of tariffs and trade war uncertainty, companies are using U.S. Customs-sanctioned foreign trade zones (FTZs) and bonded warehouses to delay or reduce product taxes. FTZs have a long history dating back to a previous period of trade conflict, created during the Great Depression by Congress to encourage international trade and […]
Read More
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
U.S. President Donald Trump presents a sweeping spending and tax legislation, known as the “One Big Beautiful Bill Act,” after he signed it, at the White House in Washington, D.C., U.S., July 4, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care […]
Read More
Tripadvisor stock surges 10% as Starboard Value builds sizable stake in online travel company
The Tripadvisor logo is displayed on a tablet. Mateusz Slodkowski | Sopa Images | Lightrocket | Getty Images Tripadvisor stock jumped 10% Thursday after Starboard Value revealed a more than 9% stake in the online travel company, according to a securities filing. The position was valued at about $160 million as of Wednesday’s close. Tripadvisor […]
Read More